Brief: Instil Bio Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Corporate Update

Instil Bio

07/03/2022 12:42

March 7 (Reuters) - Instil Bio Inc  TIL.O :
    * INSTIL BIO REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * INSTIL BIO INC - RECEIVED ORPHAN DRUG AND FAST-TRACK
DESIGNATION
FROM U.S. FDA FOR LEAD PIPELINE CANDIDATE, ITIL-168, IN MELANOMA
    * INSTIL BIO INC - EXPANSION OF MANUFACTURING CAPACITY IN
MANCHESTER, UK, WITH TARZANA, CALIFORNIA FACILITY EXPECTED
ONLINE IN 1H 2022
    * INSTIL BIO INC - EXPECTS CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES AS OF DECEMBER 31, 2021 WILL ENABLE IT TO FUND ITS
OPERATING PLAN INTO 2023

Source text for Eikon:  ID:nGNX9GRLWt 
Further company coverage:  TIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))